Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5551

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML ; volume:36 ; number:10 ; day:2 ; month:9 ; year:2022 ; pages:2418-2429 ; date:10.2022
Leukemia ; 36, Heft 10 (2.9.2022), 2418-2429, 10.2022

Creator: Allert, Catana
Waclawiczek, Alexander
Zimmermann, Sarah Miriam Naomi
Göllner, Stefanie
Heid, Daniel
Janssen, Maike
Renders, Simon
Rohde, Christian
Bauer, Marcus
Bruckmann, Margarita
Zinz, Rafael
Pauli, Cornelius
Besenbeck, Birgit
Wickenhauser, Claudia
Trumpp, Andreas
Krijgsveld, Jeroen
Müller-Tidow, Carsten
Blank, Maximilian Felix

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41375-022-01687-x

URN: urn:nbn:de:101:1-2022121709100301637524

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Allert, Catana
Waclawiczek, Alexander
Zimmermann, Sarah Miriam Naomi
Göllner, Stefanie
Heid, Daniel
Janssen, Maike
Renders, Simon
Rohde, Christian
Bauer, Marcus
Bruckmann, Margarita
Zinz, Rafael
Pauli, Cornelius
Besenbeck, Birgit
Wickenhauser, Claudia
Trumpp, Andreas
Krijgsveld, Jeroen
Müller-Tidow, Carsten
Blank, Maximilian Felix
SpringerLink (Online service)

Other Objects (12)

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Hochschulschrift

Receptor tyrosine kinase activation in human carcinoma cells

Hochschulschrift

An inducible tyrosine kinase receptor for axonal regeneration

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Hochschulschrift

Receptor tyrosine kinase activation in human carcinoma cells

Hochschulschrift

An inducible tyrosine kinase receptor for axonal regeneration

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Hochschulschrift

Receptor tyrosine kinase activation in human carcinoma cells

Hochschulschrift

An inducible tyrosine kinase receptor for axonal regeneration

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Receptor tyrosine kinase activation in human carcinoma cells

An inducible tyrosine kinase receptor for axonal regeneration

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Receptor tyrosine kinase activation in human carcinoma cells

An inducible tyrosine kinase receptor for axonal regeneration

Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD

Editorial: Targeting bruton tyrosine kinase

Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer

Newer Tyrosine Kinase Inhibitors for CML

Second-generation inhibitors of Bruton tyrosine kinase

Targeting tumour microenvironment by tyrosine kinase inhibitor

Bcr-Abl tyrosine kinase inhibitors- current status

Auto-thiophosphorylation activity of Src tyrosine kinase

VEGFR1-tyrosine kinase signaling in pulmonary fibrosis

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer

Receptor tyrosine kinase activation in human carcinoma cells

An inducible tyrosine kinase receptor for axonal regeneration

Related objects

Reset password